Colin D Steer1, Eva Lattka, Berthold Koletzko, Jean Golding, Joseph R Hibbeln. 1. School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom (CDS and JG); the Research Unit for Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (EL); the Department of Pediatrics, Dr von Hauner Children's Hospital, University of Munich Medical Center, München, Germany (BK); and the NIH, National Institute on Alcohol Abuse and Alcoholism, Bethesda MD (JRH).
Abstract
BACKGROUND: Brain tissue is selectively enriched with highly unsaturated fatty acids (FAs). Altering the maternal FA status in pregnancy may improve fetal neural development with lasting consequences for child development. OBJECTIVE: We explored whether maternal FAs in erythrocytes, either measured directly or indirectly by maternal FADS genetic variants, are associated with child intelligence quotient (IQ). DESIGN: Linear regression analyses, adjusted for 18 confounders, were used to investigate the associations in 2839 mother-child pairs from the population-based Avon Longitudinal Study of Parents and Children cohort. RESULTS: Low levels of arachidonic acid (20:4n-6) were associated with lower performance IQ (-2.0 points; 95% CI: -3.5, -0.6 points; P = 0.007, increased R² = 0.27%), high levels of osbond acid (22:5n-6) were associated with verbal IQ (-1.8 points; 95% CI: -3.2, -0.4 points; P = 0.014, R² = 0.20%), and high levels of adrenic acid (22:4n-6) were associated with verbal IQ (-1.7 points; 95% CI:-3.1, -0.3 points; P = 0.016, R² = 0.19%). There was some evidence to support a negative association of low docosahexaenoic acid (DHA; 22:6n-3) with full-scale IQ (R² = 0.15%). Novel weak associations were also observed for low levels of osbond acid (R² ≤ 0.29%) and FADS variants with opposite effects for intron variants and variants in the promoter region such as rs3834458 (R² ≤ 0.38%). CONCLUSIONS: These results support the positive role of maternal arachidonic acid and DHA on fetal neural development, although the effects on child IQ by 8 y of age were small (0.1 SD), with other factors contributing more substantially. The endogenous synthesis of these FAs by FADS genes, especially FADS2, may also be important. The replication of these results is recommended.
BACKGROUND: Brain tissue is selectively enriched with highly unsaturated fatty acids (FAs). Altering the maternal FA status in pregnancy may improve fetal neural development with lasting consequences for child development. OBJECTIVE: We explored whether maternal FAs in erythrocytes, either measured directly or indirectly by maternal FADS genetic variants, are associated with child intelligence quotient (IQ). DESIGN: Linear regression analyses, adjusted for 18 confounders, were used to investigate the associations in 2839 mother-child pairs from the population-based Avon Longitudinal Study of Parents and Children cohort. RESULTS: Low levels of arachidonic acid (20:4n-6) were associated with lower performance IQ (-2.0 points; 95% CI: -3.5, -0.6 points; P = 0.007, increased R² = 0.27%), high levels of osbond acid (22:5n-6) were associated with verbal IQ (-1.8 points; 95% CI: -3.2, -0.4 points; P = 0.014, R² = 0.20%), and high levels of adrenic acid (22:4n-6) were associated with verbal IQ (-1.7 points; 95% CI:-3.1, -0.3 points; P = 0.016, R² = 0.19%). There was some evidence to support a negative association of low docosahexaenoic acid (DHA; 22:6n-3) with full-scale IQ (R² = 0.15%). Novel weak associations were also observed for low levels of osbond acid (R² ≤ 0.29%) and FADS variants with opposite effects for intron variants and variants in the promoter region such as rs3834458 (R² ≤ 0.38%). CONCLUSIONS: These results support the positive role of maternal arachidonic acid and DHA on fetal neural development, although the effects on child IQ by 8 y of age were small (0.1 SD), with other factors contributing more substantially. The endogenous synthesis of these FAs by FADS genes, especially FADS2, may also be important. The replication of these results is recommended.
Authors: Jordi Rumià; Frederic Marmol; Juan Sanchez; Mar Carreño; Núria Bargalló; Teresa Boget; Luis Pintor; Xavier Setoain; Eva Bailles; Antonio Donaire; Enric Ferrer; Pere Puig-Parellada Journal: Epilepsy Res Date: 2011-11-21 Impact factor: 3.045
Authors: C R Gale; S M Robinson; N C Harvey; M K Javaid; B Jiang; C N Martyn; K M Godfrey; C Cooper Journal: Eur J Clin Nutr Date: 2007-02-21 Impact factor: 4.016
Authors: Eva Lattka; Berthold Koletzko; Sonja Zeilinger; Joseph R Hibbeln; Norman Klopp; Susan M Ring; Colin D Steer Journal: Br J Nutr Date: 2012-08-09 Impact factor: 3.718
Authors: C Brei; L Stecher; S Brunner; R Ensenauer; F Heinen; P D Wagner; J Hermsdörfer; H Hauner Journal: Eur J Clin Nutr Date: 2017-05-24 Impact factor: 4.016
Authors: Marie C Conway; Emeir M McSorley; Maria S Mulhern; J J Strain; Edwin van Wijngaarden; Alison J Yeates Journal: Nutr Rev Date: 2020-08-01 Impact factor: 7.110
Authors: Alison J Yeates; Tanzy M Love; Karin Engström; Maria S Mulhern; Emeir M McSorley; Katherine Grzesik; Ayman Alhamdow; Karin Wahlberg; Sally W Thurston; Philip W Davidson; Edwin van Wijngaarden; Gene E Watson; Conrad F Shamlaye; G J Myers; J J Strain; Karin Broberg Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2015-09-14 Impact factor: 4.006